Innovation in science
Saturday, April 17, 2010 - 07:14
in Health & Medicine
Results of a study presented today at the International Liver CongressTM 2010 demonstrate that a dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a...